ARGX

NASDAQ HEALTHCARE

argenx NV ADR

$882.48

$13.15 (+1.51%)

Live quote

52w: $661.85 – $1,072.75

Loading chart…

P/E Ratio41.64

P/B Ratio7.35

EV/EBITDA—

Debt/Equity—

ROE17.64%

ROIC—

Revenue Growth254.41%

Gross Margin—

argenx SE, a clinical-phase biotechnology company, focuses on the development of antibody-based therapies for the treatment of autoimmune diseases, hematology and cancer. The company is headquartered in Breda, the Netherlands.

Own ARGX? Track it here.

Create a free account to add ARGX to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account